News
The NIH faces cuts of 35 percent, requested by billionaire Elon Musk’s so-called Department of Government Efficiency (DOGE).
A Washington DC man was left excessively bleeding due to a rare side effect linked to his Covid vaccine booster.
The discerning mediavore’s take on the news of the day, from city hall to Power Ball. Visit our City page for all the latest.
San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...
RNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines against several influenza strains and SARS-CoV-2.
10h
MarketBeat on MSNBest Biotech Stocks to Buy in 2025The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered ...
MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...
Axon named Tina Hahn as president and managing partner. Bristol Myers Squibb promoted Cari Gallman to EVP, general counsel ...
A new trial suggests a combination vaccine may offer equal or better protection against both flu and covid-19 compared to ...
We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this ...
I am a 77-year-old female in good health. I am up to date on all vaccines, but I would like to know why after each COVID shot ...
A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results